"Potential Survival Gains from First-line (1L) Systemic Therapy Advances in Metastatic Triple-negative Breast Cancer (mTNBC)" by Reshma Mahtani

Article

Potential Survival Gains from First-line (1L) Systemic Therapy Advances in Metastatic Triple-negative Breast Cancer (mTNBC)

Annals of Oncology / 43rd. European Society for Medical Oncology. ESMO Congress (2018)

Reshma Mahtani, Baptist Health South Florida
P. Bajaj
J. Roth
S. Sullivan
A. Stein
S. Ramsey

Link

Disciplines

Medicine and Health Sciences

Publication Date

2018

Citation Information

Reshma Mahtani, P. Bajaj, J. Roth, S. Sullivan, et al.. "Potential Survival Gains from First-line (1L) Systemic Therapy Advances in Metastatic Triple-negative Breast Cancer (mTNBC)" Annals of Oncology / 43rd. European Society for Medical Oncology. ESMO Congress Vol. 29 Iss. suppl. 8 (2018) p. viii114 - viii114
Available at: http://works.bepress.com/reshma-mahtani/20/